VENTXP1: A Potential Drug Target and Biomarker (G139538)

Target Name: VENTXP1

NCBI ID: G139538

VENTXP1

Other Name(s): NA88A | VENTX2P1 | VENT homeobox pseudogene 1 | CT18

VENTXP1: A Potential Drug Target and Biomarker

Ventxp1, a gene encoding a protein called X-protein, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. The protein encoded by VENTXP1 has unique features that make it an attractive target for drug development due to its stability, expression level constancy and interactions with other proteins.

The discovery of VENTXP1 as a potential drug target and biomarker has been made through a combination of genetic, biochemical, and functional assays. Initial studies identified a significant increase in the expression level of VENTXP1 in various human tissues and fluids, including blood, urine, and cancer samples. The protein was also shown to be expressed in a variety of cancer cell types, suggesting that it may be a promising target for cancer therapies.

Furthermore, VENTXP1 has been shown to play a role in several cellular processes that are involved in cancer development and progression. For example, VENTXP1 has been shown to be involved in cell adhesion, migration, and invasion, which are critical steps in the development of cancer. Additionally, the protein has been shown to be involved in the regulation of cell survival and apoptosis, which are important processes that are altered in cancer cells.

In addition to its potential role as a drug target, VENTXP1 has also been identified as a potential biomarker for several diseases. The protein has been shown to be involved in several physiological processes that are important for human health, including growth, development, and immune function. Therefore, changes in the expression level of VENTXP1 may be an indication of disease and can be used as biomarkers for monitoring disease progression and treatment response.

The potential utility of VENTXP1 as a drug target and biomarker makes it an attractive candidate for further study. Further studies are needed to determine the exact mechanism of VENTXP1's involvement in cancer development and progression, as well as its potential as a biomarker for disease. Additionally , the development of small molecules or other compounds that can inhibit or activate VENTXP1's activity would be a valuable addition to the study of VENTXP1's potential as a drug target and biomarker.

In conclusion, VENTXP1 is a gene that encodes a protein with unique features that make it an attractive target for drug development. Its stability, expression level constancy and interactions with other proteins make it an attractive candidate as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Further studies are needed to fully understand its potential as a drug target and biomarker, and the development of small molecules or other compounds that can inhibit or activate its activity would be a valuable addition to the study of its potential.

Protein Name: VENT Homeobox Pseudogene 1

The "VENTXP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VENTXP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets